ORIGINAL RESEARCH article
Front. Med.
Sec. Ophthalmology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1630425
This article is part of the Research TopicNew Concepts, Advances, and Future Trends in Clinical Research on Eye DiseasesView all 43 articles
A preliminary study on the clinical characteristics of lacrimal duct obstruction in patients with a history of anterior uveitis
Provisionally accepted
- Third medical center of the PLA General Hospital, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
AIM: To investigate the clinical features of lacrimal duct obstruction (LDO) in patients with a history of anterior uveitis (AU) and explore preventive strategies by analyzing their demographic, anatomical, and surgical outcome profiles.We retrospectively reviewed 40 LDO patients (58 eyes) with a history of AU treated between 2020-2024, comparing them to non-AU LDO controls. Data included demographics, AU-epiphora temporal relationships, obstruction characteristics (location, extent, adhesions), and surgical outcomes. Statistical analysis evaluated differences between groups.The mean age was 49.88±10.18years with 30 females (75%) and 10 males (25%). Proximal lacrimal canalicular obstruction (<4 mm from lacrimal punctum) occurred in 32 cases (80%), comprising 16 cases of lacrimal punctal atresia, 6 cases of proximal lacrimal canalicular obstruction, and 10 cases with a combination of both conditions. Additional cases included one (2.5%) middle lacrimal canalicular obstruction and two (5%) distal lacrimal canalicular obstructions. Three (7.5%) had proximal and distal lacrimal canalicular obstructions, one (2.5%) had proximal and middle lacrimal canalicular obstruction, and one (2.5%) had middle and distal lacrimal canalicular obstruction. Among 11 patients with ankylosing spondylitis, anterior uveitis onset averaged 10.02±9.34 years, with epiphora preceding uveitis by an average of 3.24±3.42 years. Intraoperatively, 32 patients (80%) showed extensive adhesive lacrimal duct obstruction. Surgical procedures included laser canaliculoplasty with lacrimal stent intubation (55 eyes), dacryocystorhinostomy with lacrimal stent intubation (one eye), and retrograde canalicular trephination combined with dacryocystorhinostomy and lacrimal stent intubation (two eyes). Treatment outcomes showed a complete cure in 8 cases (20%), improvement in 21 cases (52.5%), and no effect in 11 cases (27.5%). The surgical success rates were significantly lower in uveitis patients compared to controls (p<0.001), with extensive adhesions observed intraoperatively in 80% of uveitis cases.In patients with a history of anterior uveitis (AU), lacrimal duct obstruction (LDO) predominantly affects the proximal lacrimal structures, often resulting in severe adhesions and poor surgical outcomes, with a cure rate of only 20%. The temporal link between epiphora and AU onset suggests shared pathophysiology. Targeted research is critical to clarify AU-LDO mechanisms and optimize prevention.
Keywords: Lacrimal Duct Obstruction, Anterior uveitis, clinical characteristic, Diagnosis and therapy, Surgery method, Therapeutic effect
Received: 20 May 2025; Accepted: 13 Jun 2025.
Copyright: © 2025 Wang, Tao, Wang, Bai, zhou, wang, liu and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yifei Huang, Third medical center of the PLA General Hospital, Beijing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.